Celiac Disease Market Size and Revenue Impact Study 2026 to 2035

Report Id: 2874 Pages: 168 Last Updated: 21 October 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Celiac Disease Market :

Celiac Disease Market By Treatments-

  • Infliximab
  • Larazotide Acetate
  • Gluten-Free Diet
  • Others

celiac disease

Celiac Disease Market By Route of Administration-

  • Oral
  • Parenteral

Celiac Disease Market By End-Users-

  • Hospitals
  • Homecare
  • Others

Celiac Disease Market By Distribution Channels-

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Celiac Disease Market By Region-

  • North America-
    • The US
    • Canada
  • Europe-
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific-
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest of Asia Pacific
  • Latin America-
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  •  Middle East & Africa-
    • GCC Countries
    • South Africa
    • Rest of Middle East and Afric

Chapter 1.       Methodology and Scope

1.1.      Research Methodology

1.2.      Research Scope & Assumptions

Chapter 2.       Executive Summary

Chapter 3.       Global Celiac Disease Market Snapshot

Chapter 4.       Global Celiac Disease Market Variables, Trends & Scope

4.1.      Market Segmentation & Scope

4.2.      Drivers

4.3.      Challenges

4.4.      Trends

4.5.      Investment and Funding Analysis

4.6.      Porter's Five Forces Analysis

4.7.      Incremental Opportunity Analysis (US$ MN), 2024-2031

4.8.      Global Celiac Disease Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031

4.9.      Competitive Landscape & Market Share Analysis, By Key Player (2023)

4.10.    Use/impact of AI on Celiac Disease Industry Trends

Chapter 5.       Celiac Disease Market Segmentation 1: By Treatments, Estimates & Trend Analysis

5.1.      Market Share by Treatments, 2023 & 2031

5.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Treatments:

5.2.1.   Infliximab

5.2.2.   Larazotide Acetate

5.2.3.   Gluten Free Diet

5.2.4.   Others

Chapter 6.       Celiac Disease Market Segmentation 2: By Route of Administrations, Estimates & Trend Analysis

6.1.      Market Share by Route of Administrations, 2023 & 2031

6.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Route of Administrationss:

6.2.1.   Oral

6.2.2.   Parenteral

Chapter 7.       Celiac Disease Market Segmentation 3: By Distribution Channels, Estimates & Trend Analysis

7.1.      Market Share by Distribution Channels, 2023 & 2031

7.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channelss:

7.2.1.   Hospital Pharmacy

7.2.2.   Online Pharmacy

7.2.3.   Retail Pharmacy

Chapter 8.       Celiac Disease Market Segmentation 4: By End-Users Industry, Estimates & Trend Analysis

8.1.      Market Share by End-Users Industry, 2023 & 2031

8.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-Users Industrys:

8.2.1.   Hospitals

8.2.2.   Homecare

8.2.3.   Others

Chapter 9.       Celiac Disease Market Segmentation 5: Regional Estimates & Trend Analysis

9.1.      Global Celiac Disease Market, Regional Snapshot 2023 & 2031

9.2.      North America

9.2.1.   North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

9.2.1.1.            US

9.2.1.2.            Canada

9.2.2.   North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031

9.2.3.   North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031

9.2.4.   North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channels, 2024-2031

9.2.5.   North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031

9.3.      Europe

9.3.1.   Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

9.3.1.1.            Germany

9.3.1.2.            U.K.

9.3.1.3.            France

9.3.1.4.            Italy

9.3.1.5.            Spain

9.3.1.6.            Rest of Europe

9.3.2.   Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031

9.3.3.   Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031

9.3.4.   Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channels, 2024-2031

9.3.5.   Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031

9.4.      Asia Pacific

9.4.1.   Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

9.4.1.1.            India

9.4.1.2.            China

9.4.1.3.            Japan

9.4.1.4.            Australia

9.4.1.5.            South Korea

9.4.1.6.            Hong Kong

9.4.1.7.            Southeast Asia

9.4.1.8.            Rest of Asia Pacific

9.4.2.   Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031

9.4.3.   Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031

9.4.4.   Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2024-2031

9.4.5.   Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031

9.5.      Latin America

9.5.1.   Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

9.5.1.1.            Brazil

9.5.1.2.            Mexico

9.5.1.3.            Rest of Latin America

9.5.2.   Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031

9.5.3.   Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031

9.5.4.   Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channels, 2024-2031

9.5.5.   Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031

9.6.      Middle East & Africa

9.6.1.   Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.6.1.1.            GCC Countries

9.6.1.2.            Israel

9.6.1.3.            South Africa

9.6.1.4.            Rest of Middle East and Africa

9.6.2.   Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031

9.6.3.   Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031

9.6.4.   Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channels, 2024-2031

9.6.5.   Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031

Chapter 10.     Competitive Landscape

10.1.    Major Mergers and Acquisitions/Strategic Alliances

10.2.    Company Profiles

10.2.1. Amgen

10.2.1.1.          Business Overview

10.2.1.2.          Key Product/Service Offerings

10.2.1.3.          Financial PerTreatmentsance

10.2.1.4.          Geographical Presence

10.2.1.5.          Recent Developments with Business Strategy

10.2.2. Anokion SA

10.2.3. BioLineRx Ltd

10.2.4. ChemoCentryx, Inc

10.2.5. COUR Pharmaceutical

10.2.6. F. Hoffmann-La Roche Ltd

10.2.7. ImmunogenX, LLC

10.2.8. Innovate Biopharmaceuticals

10.2.9. Takeda Pharmaceutical Company Limited

10.2.10.           Teva Pharmaceutical Industries Ltd (Israel)

10.2.11.           Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
3252
Security Code field cannot be blank!

Frequently Asked Questions

The Celiac Disease Market Size is valued at USD 581.6 Mn in 2023 and is predicted to reach USD 1,195.5 Mn by the year 2031

The Celiac Disease Market is expected to grow at a 9.8% CAGR during the forecast period for 2024-2031.

Amgen, Anokion SA, BioLineRx Ltd, ChemoCentryx, Inc, COUR Pharmaceutical, F. Hoffmann-La Roche Ltd, ImmunogenX, LLC, Innovate Biopharmaceuticals, Take

Treatments, Route Of Administration, End-Users, And Distribution Channels are the key segments of the Celiac Disease Market.

North American region is leading the Celiac Disease Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying